For example, OGT and O-GlcNAcylation may have tumor suppressor activity early in the course of MDS and AML when ASXL1 is intact (179) but acquire tumor promoting activity when ASXL1 is inactivated by mutation. This evidence concerns the gene OGT and acute myeloid leukemia.